Barclays’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $803K | Buy |
199,458
+47,981
| +32% | +$193K | ﹤0.01% | 2792 |
|
|
2025
Q1 | $414K | Sell |
151,477
-28,114
| -16% | -$76.8K | ﹤0.01% | 2941 |
|
|
2024
Q4 | $763K | Buy |
179,591
+13,437
| +8% | +$57.1K | ﹤0.01% | 2797 |
|
|
2024
Q3 | $488K | Buy |
166,154
+56,079
| +51% | +$165K | ﹤0.01% | 3004 |
|
|
2024
Q2 | $384K | Sell |
110,075
-40,651
| -27% | -$142K | ﹤0.01% | 2690 |
|
|
2024
Q1 | $429K | Sell |
150,726
-40,449
| -21% | -$115K | ﹤0.01% | 2923 |
|
|
2023
Q4 | $675K | Buy |
191,175
+54,864
| +40% | +$194K | ﹤0.01% | 2839 |
|
|
2023
Q3 | $353K | Buy |
136,311
+94,149
| +223% | +$244K | ﹤0.01% | 2734 |
|
|
2023
Q2 | $166K | Buy |
42,162
+1,341
| +3% | +$5.28K | ﹤0.01% | 3177 |
|
|
2023
Q1 | $138K | Buy |
40,821
+13,583
| +50% | +$45.9K | ﹤0.01% | 3351 |
|
|
2022
Q4 | $97K | Buy |
27,238
+12,863
| +89% | +$45.8K | ﹤0.01% | 3473 |
|
|
2022
Q3 | $58K | Sell |
14,375
-932
| -6% | -$3.76K | ﹤0.01% | 3611 |
|
|
2022
Q2 | $68K | Buy |
15,307
+3,312
| +28% | +$14.7K | ﹤0.01% | 3617 |
|
|
2022
Q1 | $102K | Buy |
+11,995
| New | +$102K | ﹤0.01% | 3656 |
|